Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate vs atomoxetine in adult ADHD
IRCT20110802007202N15Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate and atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Aug 2018; status: completed.
02
Drugs
methylphenidateatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20110802007202N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110802007202N15.